Is persistence of metabolic syndrome associated with poor health-related quality of life in non-diabetic Iranian adults? Tehran Lipid and Glucose Study - Test2 - elhamkhani - TriplyDB

Is persistence of metabolic syndrome associated with poor health-related quality of life in non-diabetic Iranian adults? Tehran Lipid and Glucose Study

Is persistence of metabolic syndrome associated with poor health-related quality of life in non-diabetic Iranian adults? Tehran Lipid and Glucose Study

http://www.wikidata.org/entity/Q34523714

about

Impact of Worsened Metabolic Syndrome on the Risk of Dementia: A Nationwide Cohort Study

P2860

Q42373661-19762F3B-92AB-4439-892B-A35F2BE57EB9

P2860

Is persistence of metabolic syndrome associated with poor health-related quality of life in non-diabetic Iranian adults? Tehran Lipid and Glucose Study

http://www.wikidata.org/entity/Q34523714

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@ast

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@en

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@nl

type

label

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@ast

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@en

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@nl

prefLabel

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@ast

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@en

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@nl

P1433

Q34523714-8DF98D9E-1941-4368-827B-049FD2BD2EF0

P1476

Q34523714-59793E6E-F6A2-4E2B-9AE3-64471CA39718

P2093

Q34523714-328C6D78-E4F1-4A2D-AFE7-38D58EEACD42

Q34523714-AEBC541C-16F4-4237-8953-3C92AB561BAE

P2860

Q34523714-0120FC6D-C7A9-410B-8DBF-B34DF50BCC5D

Q34523714-05799775-88C0-4351-A16F-E1392C9AC8F9

Q34523714-11E7F1AA-6B41-4C89-B467-80A25CB6CD8F

Q34523714-2045F250-21B1-4F58-8984-C925DF2B12E5

Q34523714-228996DF-8356-4493-A2CE-4C9AB7E6EE43

Q34523714-26C9BEBA-31F1-44C7-98B4-873CFC1EF476

Q34523714-462B726D-46C0-4C89-A09E-B5200225A624

Q34523714-46BC6AFD-2EC6-4B94-96DB-0655C7ED5194

Q34523714-487A5954-8D7F-4837-A4D6-B2C070F100C6

Q34523714-4A1554DD-38C4-47B4-A90D-23E3E7854795

P304

Q34523714-9C8EC179-FFB4-4E17-95A4-3547ADCBEBC0

P31

Q34523714-C85B2B26-3038-423A-934B-2C248262B453

P356

Q34523714-199C6722-B5E2-45E5-850E-FA2565BBFBCC

P433

Q34523714-2343DB07-BA21-4DA4-A5EE-72E74D763D81

P478

Q34523714-3BB683E5-323C-40EA-ABC8-0DD25678A9C8

P50

Q34523714-30BAC084-31FA-4699-8D15-2BB9DE3FD428

Q34523714-91091AAB-DE02-44DA-A61C-D3DF3F622C06

Q34523714-96F6AE6C-AB3C-4A6B-A7C6-13180BDCD5C0

Q34523714-BAB5F80B-BFDF-4D15-AC5A-ECD7B73B2511

Q34523714-CD401D5E-C227-4E41-AC78-2129B9A1C5A2

P577

Q34523714-82B0CB39-8548-4FD8-A448-15594DBC7100

P5875

Q34523714-18B2CE59-2F64-4766-8F0A-7874B2D5F4C8

P698

Q34523714-867621BF-7F84-4740-8FF0-F0A4505C6A16

P921

Q34523714-1F5929D0-6F77-40A8-8B45-BECAC1DDF58E

P932

Q34523714-DD100522-46B4-452D-BD1A-B9BF27A4EAC7

P356

P1433

Journal of Diabetes Investigation

P1476

Is persistence of metabolic sy ...... Tehran Lipid and Glucose Study

@en

P2093

Farhad Hosseinpanah

http://www.w3.org/2001/XMLSchema#string

Fereidoun Azizi

http://www.w3.org/2001/XMLSchema#string

P2860

Medical Consequences of Obesity

Gender differences in cardiovascular disease and comorbid depression

Report of the committee on the classification and diagnostic criteria of diabetes mellitus

Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.

Health related quality of life in patients with chronic kidney disease.

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II.

What are quality of life measurements measuring?

First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.

P304

687-693

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDI.12222

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Yadollah Mehrabi

Sara Jalali-Farahani

P577

2014-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261106981

http://www.w3.org/2001/XMLSchema#string

P698

25422769

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

4234232

http://www.w3.org/2001/XMLSchema#string